These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22425803)

  • 21. Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
    Kopec K; Flood DG; Gasior M; McKenna BA; Zuvich E; Schreiber J; Salvino JM; Durkin JT; Ator MA; Marino MJ
    Biochem Pharmacol; 2010 Nov; 80(9):1407-17. PubMed ID: 20637735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcosine preconditioning induces ischemic tolerance against global cerebral ischemia.
    Pinto MC; Simão F; da Costa FL; Rosa DV; de Paiva MJ; Resende RR; Romano-Silva MA; Gomez MV; Gomez RS
    Neuroscience; 2014 Jun; 271():160-9. PubMed ID: 24797328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycine transporter-1: a new potential therapeutic target for schizophrenia.
    Hashimoto K
    Curr Pharm Des; 2011; 17(2):112-20. PubMed ID: 21355838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycine transporter blockade ameliorates motor ataxia in a mouse model of spinocerebellar atrophy.
    Tanabe M; Nakano T; Honda M; Ono H
    J Pharmacol Sci; 2009 Mar; 109(3):444-8. PubMed ID: 19270429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycine transporter type-1 and its inhibitors.
    Harsing LG; Juranyi Z; Gacsalyi I; Tapolcsanyi P; Czompa A; Matyus P
    Curr Med Chem; 2006; 13(9):1017-44. PubMed ID: 16611082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of hypoxia-induced [(3)H]glycine release from chicken retina by the glycine transporter type-1 (GlyT-1) inhibitors NFPS and Org-24461.
    Harsing LG; Albert M; Matyus P; Szenasi G
    Exp Eye Res; 2012 Jan; 94(1):6-12. PubMed ID: 22079563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study.
    Harsing LG; Gacsalyi I; Szabo G; Schmidt E; Sziray N; Sebban C; Tesolin-Decros B; Matyus P; Egyed A; Spedding M; Levay G
    Pharmacol Biochem Behav; 2003 Mar; 74(4):811-25. PubMed ID: 12667895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycine transporter inhibitors: A new avenue for managing neuropathic pain.
    Al-Khrasani M; Mohammadzadeh A; Balogh M; Király K; Barsi S; Hajnal B; Köles L; Zádori ZS; Harsing LG
    Brain Res Bull; 2019 Oct; 152():143-158. PubMed ID: 31302238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats.
    Shimazaki T; Kaku A; Chaki S
    Psychopharmacology (Berl); 2010 Apr; 209(3):263-70. PubMed ID: 20198471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists.
    Javitt DC; Balla A; Burch S; Suckow R; Xie S; Sershen H
    Neuropsychopharmacology; 2004 Feb; 29(2):300-7. PubMed ID: 14560321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-synaptic glycine GlyT1 transporter--NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions.
    Musante V; Summa M; Cunha RA; Raiteri M; Pittaluga A
    J Neurochem; 2011 May; 117(3):516-27. PubMed ID: 21348870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some Operational Characteristics of Glycine Release in Rat Retina: The Role of Reverse Mode Operation of Glycine Transporter Type-1 (GlyT-1) in Ischemic Conditions.
    Hanuska A; Szénási G; Albert M; Koles L; Varga A; Szabo A; Matyus P; Harsing LG
    Neurochem Res; 2016 Feb; 41(1-2):73-85. PubMed ID: 26364050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?
    Singer P; Dubroqua S; Yee BK
    Curr Pharm Des; 2015; 21(26):3771-87. PubMed ID: 26205290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
    Mallorga PJ; Williams JB; Jacobson M; Marques R; Chaudhary A; Conn PJ; Pettibone DJ; Sur C
    Neuropharmacology; 2003 Oct; 45(5):585-93. PubMed ID: 12941372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term application of glycine transporter inhibitors acts antineuropathic and modulates spinal N-methyl-D-aspartate receptor subunit NR-1 expression in rats.
    Barthel F; Urban A; Schlösser L; Eulenburg V; Werdehausen R; Brandenburger T; Aragon C; Bauer I; Hermanns H
    Anesthesiology; 2014 Jul; 121(1):160-9. PubMed ID: 24598217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycine transporters type 1 inhibitor promotes brain preconditioning against NMDA-induced excitotoxicity.
    Pinto MC; Lima IV; da Costa FL; Rosa DV; Mendes-Goulart VA; Resende RR; Romano-Silva MA; de Oliveira AC; Gomez MV; Gomez RS
    Neuropharmacology; 2015 Feb; 89():274-81. PubMed ID: 25312280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.
    Tsai G; Lane HY; Yang P; Chong MY; Lange N
    Biol Psychiatry; 2004 Mar; 55(5):452-6. PubMed ID: 15023571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycine transport inhibitors in the treatment of schizophrenia.
    Javitt DC
    Handb Exp Pharmacol; 2012; (213):367-99. PubMed ID: 23027421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.